Cargando…
Microtiter plate-based antibody-competition assay to determine binding affinities and plasma/blood stability of CXCR4 ligands
C-X-C chemokine receptor type 4 (CXCR4) is involved in several intractable disease processes, including HIV infection, cancer cell metastasis, leukemia cell progression, rheumatoid arthritis, asthma and pulmonary fibrosis. Thus, CXCR4 represents a promising drug target and several CXCR4 antagonizing...
Autores principales: | Harms, Mirja, Gilg, Andrea, Ständker, Ludger, Beer, Ambros J., Mayer, Benjamin, Rasche, Volker, Gruber, Christian W., Münch, Jan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7525492/ https://www.ncbi.nlm.nih.gov/pubmed/32994431 http://dx.doi.org/10.1038/s41598-020-73012-4 |
Ejemplares similares
-
Development
of N-Terminally Modified Variants
of the CXCR4-Antagonistic Peptide EPI-X4 for Enhanced Plasma Stability
por: Harms, Mirja, et al.
Publicado: (2023) -
Computational modeling and experimental validation of the EPI-X4/CXCR4 complex allows rational design of small peptide antagonists
por: Sokkar, Pandian, et al.
Publicado: (2021) -
Adsorptive Microtiter
Plates As Solid Supports in
Affinity Purification Workflows
por: Klont, Frank, et al.
Publicado: (2021) -
From Microtiter Plates to Droplets—There and Back Again †
por: Henkel, Thomas, et al.
Publicado: (2022) -
Absence of the CXCR4 antagonist EPI-X4 from pharmaceutical human serum albumin preparations
por: Gilg, Andrea, et al.
Publicado: (2021)